The effectiveness of honey for the management of radiotherapy-induced oral mucositis in head and neck cancer patients: A systematic review of clinical trials

European Journal of Integrative Medicine

Volumn 5, Issue 3, 2013, Pages 217-225

  Charalambous, Melanie ^a   Raftopoulos, Vasilios ^a   Lambrinou, Ekaterini ^a   Charalambous, Andreas ^a  

^a CYPRUS UNIVERSITY OF TECHNOLOGY   (Cyprus)

Author keywords

Clinical trials; Head and neck cancer; Honey; Oral mucositis; Radiation therapy

Indexed keywords

NATURAL PRODUCT;

CANCER RADIOTHERAPY; DISEASE ASSOCIATION; DRUG EFFICACY; HEAD AND NECK CANCER; HONEY; HUMAN; IATROGENIC DISEASE; ORAL MUCOSITIS; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SHORT SURVEY; SYSTEMATIC REVIEW;

EID: 84878159242     PISSN: 18763820     EISSN: 18763839     Source Type: Journal    
DOI: 10.1016/j.eujim.2013.01.003     Document Type: Short Survey

References (52)

1. American Cancer society. Cancer facts & figures Atlanta: American Cancer Society. Available at: (accessed 12.04.11). http://www.cancer.org./downloads/STT/Cancer-Facts-and-Figures-2010.
2. De Vita V., Lawrence T., Rosenberg S. Cancer: principles & practice of oncology 2008, Lippincott Williams & Wilkins, Philadelphia, PA. 8th ed.
3. Jemal A., Siegel R., Xu J., Ward E. Cancer statistics. CA: A Cancer Journal for Clinicians 2010, 60:277-300.
4. Scully C., Epstein J.B. Oral health care for the cancer patient. Oral Oncology European Journal of Cancer 1996, 32B:281-292.
5. National Comprehensive Cancer Network Head and Neck Cancers: Clinical Practice Guidelines in Oncology 2011, 9(6). Available at: www.NCCN.org.
6. Sonis S.T. The pathobiology of mucositis. Nature Reviews of Cancer 2004, 4:277-284.
7. Dische S., Saunders M., Barrett A., Harvey A., Gibson D., Parmar M. Accelerated fractionation (AF) compared to conventional fractionation (CF). Improve loco-regional control in the radiotherapy of advanced head and neck cancer: results of the EORTC 22851 trial. Radiotherapy and Oncology 1997, 44:123-136.
8. McGuire D.B., Correa M.E., Johnson J., Wienandts P. The role of basic oral care and good clinical practice principles in the management of oral mucositis. Support Care Cancer 2006, 14:541-547.
9. Shieh S.H., Wang S.T., Tsai S.T., Tseng C.C. Mouth care for nasopharyngeal cancer patients undergoing radiotherapy. Oral Oncology 1997, 33:36-41.
10. Lalla R.V., Schubert M.M., Bensadoun R.J., Keefe D. Anti-inflammatory agents in themanagement of alimentary mucositis. Support Care Cancer 2006, 14(6):558-565.
11. Mahood D.J., Dose A.M., Loprinzi C.L., Veeder M.H., Athmann L.M., Therneau T.M., et al. Inhibition of fluorouracil-induced stomatitis by oral cryotherapy. Journal of Clinical Oncology 1991, 9:449-452.
12. Barasch A., Peterson D.E., Tanzer J.M., D'Ambrosio J.A., Nuki K., Schubert M.M., et al. Helium-neon laser effects on conditioning-induced oral mucositis in bone marrow transplantation. Cancer 1995 Dec 15, 76(12):2550-2556.
13. Spielberger R., Stiff P., Bensinger W., Gentile T., Weisdorf D., Kewalramani T., et al. Palifermin for oral mucositis after intensive therapy for hematologic cancers. New England Journal of Medicine 2004, 351:2590-2598.
14. Wyminga A.N., van der Graaf W.T., Hofstra L.S., Spijkervet F.K.L., Timens W., Timmer-Bosscha H., et al. Phase I study of transforming growth factor-beta3 mouthwashes for prevention of chemotherapy-induced mucositis. Clinical Cancer Research 1999, 5:1363-1368.
15. Foncuberta M.C., Cagnoni P.J., Brandts C.H., Mandanas R., Fields K., Derigs H.G., et al. Topical transforming growth factor-beta3 in the prevention or alleviation of chemotherapy-induced oral mucositis in patients with lymphomas or solid tumors. Journal of Immunotherapy 2001, 24:384-388.
16. Clarkson J.E., Worthington H.V., Eden O.B. Interventions for treating oral mucositis for patients with cancer receiving treatment. Cochrane Database of Systematic Reviews 2007, CD001973.
17. Ernst E. Prevalence of use of complementary/alternative medicine: a systematic review. Bulletin of the World Health Organization 2000, 78:393-396.
18. Molassiotis A., Fernadez-Ortega, Pud D., Ozden G., Scott J.A., Pandeli V., et al. Use of complementary and alternative medicine in cancer patients: a European survey. Annals of Oncology 2005, 16:655-663.
19. Simon L., Prebay D., Beretz A., Bagot A., Lobstein A., Rubinstein I., et al. Complementary and alternative medicines taken by cancer patients. Bulletin du Cancer 2007, 94:483-488.
20. Cavanagh D., Beazley J., Ostapowicz F. Radical operation for carcinoma of the vulva. A new approach to wound healing. Journal of Obstetrics and Gynaecology of the British Commonwealth 1970, 77:1037-1040.
21. Chiba M., Idobata K., Kobayashi N., Sato Y., Muramatsu Y. Use of honey to ease the pain of stomatitis during radiotherapy. Kangogaku Zasshi. Japanese Journal of Nursing 1985, 49:171-176.
22. Smirnova I.I., Filatova E.I., Suvorov A.N., Bylinskaia E.N. The use of therapeutic/prophylactic dragee 'honey laminolact' in radiotherapy of uterine tumors. Voprosy Onkologii 2000, 46:748-750.
23. Simon A., Sofka K., Wiszniewsky G., Blaser G., Bode U., Fleischhack G. Wound care with antibacterial honey (Medihoney) in pediatric hematology-oncology. Supportive Care in Cancer 2006, 14:91-97.
24. Molan PC. Honey as a topical antibacterial agent for the treatment of effected wounds. Worldwide wounds available at: (accessed 11/2001). http://www.worldwidewounds.com/2001/november/molan/honey-as-topical-agent.html.
25. Stephen-Haynes J. Evaluation of a honey-impregnated tulle dressing in primary care. British Journal of Community Nursing Supplement 2004, 9:S21-S27.
26. Lusby P.E., Coombes A., Wilkinson J.M. Honey: a potent agent for wound healing?. Journal of Wound, Ostomy and Continence Nursing 2002, 29:295-300.
27. Hyslop P.A., Hinshow D.B., Scraufstatter I.U., Cochrane C.G., Kunz S., Vosbeck K. Hydrogen peroxide as a potent bacteriostatic antibiotic: implications for host defense. Free Radical Biology and Medicine 1995, 19:31-37.
28. Anderson I. Honey dressings in wound care. Nursing Times 2006, 102:40-42.
29. White J.W. Composition of honey. Honey. A comprehensive survey 1975, 157-206. Heinemann Edition, London. Crane E (Ed.).
30. Persano Oddo L., Piro R. Main European unifloral honeys: descriptive sheets. Apidologie 2004, 35:S38-S81.
31. Bardy J., Slevin J.N., Mais L.K., Molassiotis A. A systematic review of honey uses and its potential value within oncology care. Journal of Clinical Nursing 2008, 17:2604-2623.
32. Subrahmanyam M., Sahapure A., Nagane N. Effects of topical application of honey on burn wound healing. Annals of Burns and Fire Disasters 2001, 14:143-145.
33. Walji R., Boon H. Redefining the randomized control trial in the context of acupuncture research. Complementary Therapies in Clinical Practice 2006, 12:91-96.
34. Verhagen A.P.D.E., Vet H.C., de Bie R.A., Kessels A.G., Boers M., Knipschild P.G. Balneotherapy and quality assessment: interobserver reliability of the Maastricht criteria list and the need for blinded quality assessment. Journal of Clinical Epidemiology 1998, 51:335-341.
35. Jadad A.R., Moore R.A., Carrol D., Jenkinson C., Reynolds D.J.M., Gavaghan D.J., et al. Assessing the quality of reports of randomized clinical trials - is blinding necessary?. Controlled Clinical Trials 1996, 17:1-12.
36. Olivo S.A., Macedo L.G., Gadotti I.C., Fuentes J., Stanton T., Magee D.J. Scales to assess the quality of randomized controlled trials: a systematic review. Physical Therapy 2007, 88(2):156-175.
37. Rashad U.M., Al-Gezawy S.M., El-Gezawy E., Azzaz A.N. Honey as topical prophylaxis against radiochemotherapy-induced mucositis in head and neck cancer. The Journal of Laryngology and Otology 2009, 123:223-228.
38. Khanal B., Baliga M., Uppal N. Effect of topical honey on limitation of radiation-induced oral mucositis: an intervention study. International Journal of Oral and Maxillofacial Surgery 2010, 39:1181-1185.
39. Biswal B.M., Zakaria A., Ahmad N.M. Topical application of honey in the management of radiation mucositis: a preliminary study. Supportive Care in Cancer 2003, 11:242-248.
40. Motallebnejad M., Akram S., Moghadamnia A., Moulana Z., Omidi S. The effect of topical application of pure honey on radiation-induced mucositis: a randomized clinical trial. Journal of Contemporary Dental Practice 2008, 9:40-47.
41. Bardy J., Molassiotis A., Ryder W.D., Kathleen M., Sykes A., Yap P., et al. A double-blind, placebo-controlled, randomized trial of active manuka honey and standard oral care for radiation-induced oral mucositis. Journal of Oral and Maxillofacial Surgery 2011, (3):221-226.
42. English H.K., Pack A.R., Molan P.C. The effects of manuka honey on plaque and gingivitis: a pilot study. Journal of the International Academy of Periodontology 2004, 6:63-67.
43. Al-Waili N.S. Topical application of natural honey, beeswax and olive oil mixture for atopic dermatitis or psoriasis: partially controlled, single-blinded study. Complementary Therapies in Medicine 2003, 11:226-234.
44. Fox C. Honey as a dressing for chronic wounds in adults. British Journal of Community Nursing 2002, 7:530-534.
45. Tahmaz L., Erdemir F., Kibar Y., Cosar A., Yalcyn O. Fournier's gangrene: report of thirty-three cases and a review of the literature. International Journal of Urology 2006, 13:960-967.
46. Molan P.C. The potential of honey to promote oral wellness. General Dentistry 2001, 49:584-589.
47. Sela M., Maroz D., Gedalia L. Streptococcus mutans in saliva of normal subjects and head and neck irradiated cancer subjects after conception of honey. Journal of Oral Rehabilitation 2000, 27:269-270.
48. Maddocks-Jennings W., Wilkinson J.M., Cavanagh H.M., Shillington D. Evaluating the effects of the essential oils Leptospermum scoparium [manuka] and Kunzea ericoides (kanuka) on radiotherapy induced mucositis: a randomized, placebo controlled feasibility study. European Journal of Oncology Nursing 2009, 13:87-93.
49. World Health Organization WHO handbook for reporting the results of cancer treatment 1979, WHO Offset Publications, Geneva, Switzerland, p. 15-22.
50. Cox J.D., Stetz J., Pajak T.F. Toxicity criteria of Radiation Therapy Oncology Group (RTOG) and European Organization for Research and Treatment of Cancer (EORTC). International Journal of Radiation Oncology, Biology, Physics 1995, 31:1341-1346.
51. National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE) Version4.0 Published: May 28, 2009 (v4.03: June 14, 2010) U.S. Department of health and humanservices, National Institutes of Health (NIH) Publication No. 09-5410. http://evs.nci.nih.gov/ftp1/CTCAE/About.html.
52. Sonis S.T., Eilers J.P., Epstein J.B., LeVeque F.G., Liggett W.H., Mulagha M.T., et al. Validation of a new scoring system for the assessment of clinical trial research of oral mucositis induced by radiation or chemotherapy. Mucositis study group. Cancer 1999, 85(10):2103-2113.